None
EN
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says
['Sarita Garza']
Markets Daily
Get Kiniksa Pharmaceuticals International alerts:Check Out Our Latest Stock Analysis on Kiniksa Pharmaceuticals InternationalKiniksa Pharmaceuticals International Trading Up 1.2%Shares of KNSA traded up $0.95 during midday trading on Wednesday, reaching $80.39.
As a group, research analysts forecast that Kiniksa Pharmaceuticals International will post 1.25 EPS for the current fiscal year.
Insider Buying and Selling at Kiniksa Pharmaceuticals InternationalIn other Kiniksa Pharmaceuticals International news, insider John F. Paolini sold 58,424 shares of Kiniksa Pharmaceuticals International stock in a transaction that occurred on Friday, May 1st.
Kiniksa Pharmaceuticals International News RoundupHere are the key news stories impacting Kiniksa Pharmaceuticals International this week:Positive Sentiment: Analysts raised their price targets.
Recommended StoriesReceive News & Ratings for Kiniksa Pharmaceuticals International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kiniksa Pharmaceuticals International and related companies with MarketBeat.com's FREE daily email newsletter.